Literature DB >> 7259117

Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE.

W W Tourtellotte, B I Ma, D B Brandes, M J Walsh, A R Potvin.   

Abstract

De novo central nervous system (CNS) IgG measles antibody synthesis rate was determined in two patients with subacute sclerosing panencephalitis (SSPE). Cerebrospinal fluid and sera were incubated with different concentrations of measles virus to determine maximum absorption of IgG. The difference in IgG concentration before and after incubation was considered the amount of measles-specific IgG antibody. Various tests were done to assess the immunological specificity of the absorption test. Using our empirical formula, the de novo CNS IgG measles antibody synthesis rate for one patient with SSPE was 57 mg/day, or 59% of the total CNS IgG synthesis rate; for the other it was 145 mg/day, or 82%. Daily determination of CNS measles antibody by empirical formula provides a quantification of humoral immunity in SSPE that corrects for both passage of measles antibody across a damaged blood-brain barrier and the effect of an elevated blood antibody level.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259117     DOI: 10.1002/ana.410090607

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  Subacute sclerosing panencephalitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

2.  A new complement fixation test for the diagnosis of neurocysticercosis in cerebrospinal fluid.

Authors:  E Garcia; J Sotelo
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

3.  Immunochemical features of a case of progressive rubella panencephalitis.

Authors:  J S Wolinsky; M N Waxham; J L Hess; J J Townsend; J R Baringer
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

4.  The treatment of subacute sclerosing panencephalitis with interferon: a case report.

Authors:  F H Norris; H S Panitch; E H Denys; K Downes; K Cantell; R A Smith
Journal:  J Neurol       Date:  1986-04       Impact factor: 4.849

5.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

6.  Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection.

Authors:  D Moskophidis; J Löhler; F Lehmann-Grube
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

Review 7.  Multiple sclerosis: neuroimmunologic puzzle.

Authors:  B P Barna
Journal:  Clin Lab Med       Date:  1986-03       Impact factor: 1.935

8.  Chronic encephalomyelitis with specific increase in intrathecal mumps antibodies.

Authors:  A Vaheri; I Julkunen; M L Koskiniemi
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.